The α2AP-inactivating monoclonal antibody was also demonstrated to increase fibrinolysis in a mouse model of venous thrombosis, suggesting a role for α2AP inhibition in DVT [54]. The gene discussed is SERPINF2; the disease is Venous thrombosis.